基本信息
浏览量:103
职业迁徙
个人简介
As director of BBRI, Dr. Kumar serves as the scientific leader of NCCU’s JLC-BBRI research facilities in Durham and Kannapolis, NC (North Carolina Research Campus-NCRC). He is a cancer researcher and has been funded continuously by NIH since his first faculty appointment 15 years ago, most recently via R01 funding to study social epigenomics in prostate cancer and a U01 grant to study epigenetics of prostate cancer disparities. Throughout his career, he has obtained extramural funding in excess of $33 million in grant funds.
Dr. Kumar is also the principal investigator (PI) of the NIMHD U54 RCMI grant and directs the NCCU RCMI Center for Health Disparities Research (RCHDR). At JLC-BBRI, he is charged with providing leadership for a broadly based research portfolio that includes cancer, cardio-metabolic disorders, neuroscience, and nutrition. Dr. Kumar has the responsibility of providing scientific guidance on the planning, direction, and implementation of NCCU’s research enterprise, as well as providing leadership to individuals and teams of investigators in developing a strategic approach for increasing the innovation and competitiveness of research.
As a scientist, he brings expertise in cancer cell and molecular biology, specifically characterizing miRNAs as therapeutic targets and biomarkers for diagnosis, prognosis, and stratification. His lab currently focuses on (1) characterizing molecular targets in prostate, breast, and colon cancer; (2) microRNAs as biomarkers and therapeutic targets in prostate and breast cancer; (3) characterizing molecular targets and signaling pathways modulated by micronutrients; and most importantly, (4) enhancing minority participation in cancer research through education and training in cancer research at all levels.
Dr. Kumar has mentored many faculty, postdoctoral fellows, and high school, graduate, and undergraduate students, most of whom are from underrepresented minorities. He has over 70 peer-reviewed journal articles, 10 patents/applications, and over 100 presentations. Dr. Kumar joined NCCU in December 2016, and due to his efforts, since then JLC-BBRI has more than doubled its extramural funding. As PI, Dr. Kumar has received the largest non-title III grant in NCCU’s history ($16.3 million/5 years). In addition, he received a $3.2 million 5-year R01 grant to address social epigenetics in prostate cancer disparities. Dr. Kumar has become the NCCU faculty with the largest amount of extramural funding with more than $20 million as PI.
Dr. Kumar is also the principal investigator (PI) of the NIMHD U54 RCMI grant and directs the NCCU RCMI Center for Health Disparities Research (RCHDR). At JLC-BBRI, he is charged with providing leadership for a broadly based research portfolio that includes cancer, cardio-metabolic disorders, neuroscience, and nutrition. Dr. Kumar has the responsibility of providing scientific guidance on the planning, direction, and implementation of NCCU’s research enterprise, as well as providing leadership to individuals and teams of investigators in developing a strategic approach for increasing the innovation and competitiveness of research.
As a scientist, he brings expertise in cancer cell and molecular biology, specifically characterizing miRNAs as therapeutic targets and biomarkers for diagnosis, prognosis, and stratification. His lab currently focuses on (1) characterizing molecular targets in prostate, breast, and colon cancer; (2) microRNAs as biomarkers and therapeutic targets in prostate and breast cancer; (3) characterizing molecular targets and signaling pathways modulated by micronutrients; and most importantly, (4) enhancing minority participation in cancer research through education and training in cancer research at all levels.
Dr. Kumar has mentored many faculty, postdoctoral fellows, and high school, graduate, and undergraduate students, most of whom are from underrepresented minorities. He has over 70 peer-reviewed journal articles, 10 patents/applications, and over 100 presentations. Dr. Kumar joined NCCU in December 2016, and due to his efforts, since then JLC-BBRI has more than doubled its extramural funding. As PI, Dr. Kumar has received the largest non-title III grant in NCCU’s history ($16.3 million/5 years). In addition, he received a $3.2 million 5-year R01 grant to address social epigenetics in prostate cancer disparities. Dr. Kumar has become the NCCU faculty with the largest amount of extramural funding with more than $20 million as PI.
研究兴趣
论文共 1063 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Environmental Engineering and Management Journalno. 2 (2024): 319-329
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICSno. 8 (2024): 4370-4378
Indian Phytopathologypp.1-7, (2024)
Vinod Kumar Pal,Deepak Kumar, Anshika Gupta, Pashupati Pratap Neelratan, L. P. Purohit, Arunvir Singh,Vishal Singh,Yogendra Kumar Mishra,Ajeet Kaushik,Sanjeev K. Sharma
crossref(2024)
crossref(2024)
Komal Gupta,Basudha Sharma, Vijay Garg, Pashupati Pratap Neelratan,Vikas Kumar,Deepak Kumar,Sanjeev K. Sharma
Hybrid Advances (2024): 100160
SSRN Electronic Journal (2024)
SSRN Electronic Journal (2024)
Srikanta Pradhan, Aaryan Sanjta, Murikinati Deva Kishan Reddy, Narisetty Raviteja,Teegala Deepak Kumar
SSRN Electronic Journal (2024)
Carbohydrate Polymer Technologies and Applicationspp.100500, (2024)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn